Hon CHRIS HIPKINS: We are in conversations with Pfizer. As the director-general indicated this morning, a paediatric formulation of the vaccine has only been very recently—i.e., in the last day or so—approved by the Food and Drug Administration in the USA. I think every country will be looking at that, and in our conversations with Pfizer, the agreements that we have with Pfizer do secure us access to a paediatric dose if one should be developed.